The veterinary eye care market size has grown strongly in recent years. It will grow from $71.8 billion in 2025 to $75.43 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to rising incidence of ocular diseases in pets, growth in companion animal population, limited availability of advanced ophthalmic treatments in early years, traditional use of basic eye medications, expansion of veterinary hospitals and clinics.
The veterinary eye care market size is expected to see steady growth in the next few years. It will grow to $88.79 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to advancements in intraocular lens technology, integration of ai-powered diagnostic tools, increasing investment in veterinary eye care research, rising adoption of retina imaging systems, growing awareness of animal eye health. Major trends in the forecast period include increasing prevalence of eye disorders in companion animals, rising demand for minimally invasive ophthalmic surgeries, growth in veterinary ophthalmology clinics, adoption of advanced diagnostic devices for eye care, emphasis on preventive eye care and early detection.
The growth in the pet population is expected to drive the expansion of the veterinary eye care market in the coming years. The term 'pet population' refers to the total number of domestic animals kept by humans for companionship, emotional support, recreation, or other non-utilitarian purposes. The increase in pet population is attributed to societal shifts favoring pet ownership, advancements in veterinary medicine, and heightened awareness of the significance of pet healthcare. Veterinary eye care plays a critical role in diagnosing and treating ocular conditions in pets, thereby ensuring their overall visual health and quality of life. For instance, as reported by the American Pet Products Association (APPA) in December 2023, 66% of U.S. households owned a pet, constituting approximately 86.9 million pet-owning households in the U.S., with 46.5 million cats, 65.1 million dogs, and 2.2 million horses. Consequently, the increasing pet population is fostering growth in the veterinary eye care market.
Key companies operating in the veterinary eye care market are prioritizing the development of innovative products, such as ocular lubricants, to enhance the comfort and ocular health of animals, improve treatment outcomes, and address various eye conditions. Ocular lubricants are specialized products formulated to moisturize and safeguard the surface of animals' eyes. These lubricants play a vital role in maintaining proper hydration of the cornea and conjunctiva, offering relief from dryness, irritation, and discomfort. For instance, in April 2024, Millpledge Veterinary introduced Oculeze, a novel ocular lubricant crafted to promote eye health in animals. This product is suitable for multiple species, including dogs, cats, horses, and rabbits, and is particularly beneficial for managing conditions requiring additional moisture or lubrication to sustain eye health. The ocular lubricant contains natural active ingredients such as glycerin (0.8%), aloe vera, chamomile, and propolis extract, renowned for their soothing and hydrating properties. It is phosphate-free, pH-neutral, and suitable for various conditions necessitating additional moisture or lubrication to uphold eye health.
In August 2023, Dômes Pharma, a pharmaceutical company based in France, acquired Sentrx Animal Care for an undisclosed sum. Through this acquisition, Dômes Pharma seeks to expand its presence in North America and reinforce its global leadership in veterinary ophthalmology. Sentrx Animal Care, headquartered in the U.S., specializes in the development and manufacture of veterinary ophthalmology products.
Major companies operating in the veterinary eye care market are Boehringer Ingelheim, Zoetis Inc., Merck Animal Health, Bausch & Lomb Incorporated, Virbac, Menicon Co. Ltd., Nutramax Laboratories Inc., Manna Pro Products LLC, Farnam Companies, Bayer Animal Health, Beaphar, Revival Animal Health, MiracleCorp Products, Zymox, Domes Pharma, Epicur Pharma, TVM UK Animal Health Ltd., I-MED Animal Health, an-vision GmbH, Optixcare, MENFORSAN, Nutri-Vet, Boss Pet Products Inc.
North America was the largest region in the veterinary eye care market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary eye care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary eye care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the veterinary eye care market by increasing the cost of imported ophthalmic drugs, devices, and surgical equipment, impacting both pricing and supply chains. Regions such as asia-pacific and north america are most affected due to high import volumes of specialized devices. Segments like intraocular lenses, tonometers, and ophthalmic surgery tools have experienced cost pressures, while tariffs have incentivized local manufacturing and innovation in cost-effective and advanced veterinary eye care solutions. Overall, tariffs have prompted diversification of sourcing and localized production strategies.
The veterinary eye care market research report is one of a series of new reports that provides veterinary eye care market statistics, including veterinary eye care industry global market size, regional shares, competitors with a veterinary eye care market share, detailed veterinary eye care market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary eye care industry. This veterinary eye care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Veterinary eye care encompasses the specialized domain within veterinary medicine dedicated to diagnosing, treating, and managing eye-related ailments and disorders in animals. Its primary objective is to safeguard the visual health and welfare of animals, thereby augmenting their quality of life and facilitating their ability to carry out essential tasks and behaviors.
The principal product categories within veterinary eye care include ophthalmic drugs, ophthalmic devices, and ophthalmic surgery. Ophthalmic drugs are pharmaceuticals specifically formulated to address various eye-related conditions and diseases prevalent in animals, such as glaucoma, conjunctivitis, and dry eyes. These products cater to a diverse range of animal types, spanning companion animals to livestock, and are employed for indications such as eyelid abnormalities, cataracts, glaucoma, retinal complications, uveitis, conjunctivitis, corneal issues, among others. Veterinary hospitals, veterinary clinics, and similar facilities serve as the primary end-users of these products.
The veterinary eye care market consists of revenues earned by entities by providing services such as eye examinations, diagnostic testing, medical treatment, surgical procedures, and ongoing management. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary eye care market also includes sales of eye drops, ointments, and supplements, and specialized equipment and tools used in diagnostics and treatment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The veterinary eye care market size is expected to see steady growth in the next few years. It will grow to $88.79 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to advancements in intraocular lens technology, integration of ai-powered diagnostic tools, increasing investment in veterinary eye care research, rising adoption of retina imaging systems, growing awareness of animal eye health. Major trends in the forecast period include increasing prevalence of eye disorders in companion animals, rising demand for minimally invasive ophthalmic surgeries, growth in veterinary ophthalmology clinics, adoption of advanced diagnostic devices for eye care, emphasis on preventive eye care and early detection.
The growth in the pet population is expected to drive the expansion of the veterinary eye care market in the coming years. The term 'pet population' refers to the total number of domestic animals kept by humans for companionship, emotional support, recreation, or other non-utilitarian purposes. The increase in pet population is attributed to societal shifts favoring pet ownership, advancements in veterinary medicine, and heightened awareness of the significance of pet healthcare. Veterinary eye care plays a critical role in diagnosing and treating ocular conditions in pets, thereby ensuring their overall visual health and quality of life. For instance, as reported by the American Pet Products Association (APPA) in December 2023, 66% of U.S. households owned a pet, constituting approximately 86.9 million pet-owning households in the U.S., with 46.5 million cats, 65.1 million dogs, and 2.2 million horses. Consequently, the increasing pet population is fostering growth in the veterinary eye care market.
Key companies operating in the veterinary eye care market are prioritizing the development of innovative products, such as ocular lubricants, to enhance the comfort and ocular health of animals, improve treatment outcomes, and address various eye conditions. Ocular lubricants are specialized products formulated to moisturize and safeguard the surface of animals' eyes. These lubricants play a vital role in maintaining proper hydration of the cornea and conjunctiva, offering relief from dryness, irritation, and discomfort. For instance, in April 2024, Millpledge Veterinary introduced Oculeze, a novel ocular lubricant crafted to promote eye health in animals. This product is suitable for multiple species, including dogs, cats, horses, and rabbits, and is particularly beneficial for managing conditions requiring additional moisture or lubrication to sustain eye health. The ocular lubricant contains natural active ingredients such as glycerin (0.8%), aloe vera, chamomile, and propolis extract, renowned for their soothing and hydrating properties. It is phosphate-free, pH-neutral, and suitable for various conditions necessitating additional moisture or lubrication to uphold eye health.
In August 2023, Dômes Pharma, a pharmaceutical company based in France, acquired Sentrx Animal Care for an undisclosed sum. Through this acquisition, Dômes Pharma seeks to expand its presence in North America and reinforce its global leadership in veterinary ophthalmology. Sentrx Animal Care, headquartered in the U.S., specializes in the development and manufacture of veterinary ophthalmology products.
Major companies operating in the veterinary eye care market are Boehringer Ingelheim, Zoetis Inc., Merck Animal Health, Bausch & Lomb Incorporated, Virbac, Menicon Co. Ltd., Nutramax Laboratories Inc., Manna Pro Products LLC, Farnam Companies, Bayer Animal Health, Beaphar, Revival Animal Health, MiracleCorp Products, Zymox, Domes Pharma, Epicur Pharma, TVM UK Animal Health Ltd., I-MED Animal Health, an-vision GmbH, Optixcare, MENFORSAN, Nutri-Vet, Boss Pet Products Inc.
North America was the largest region in the veterinary eye care market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary eye care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary eye care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the veterinary eye care market by increasing the cost of imported ophthalmic drugs, devices, and surgical equipment, impacting both pricing and supply chains. Regions such as asia-pacific and north america are most affected due to high import volumes of specialized devices. Segments like intraocular lenses, tonometers, and ophthalmic surgery tools have experienced cost pressures, while tariffs have incentivized local manufacturing and innovation in cost-effective and advanced veterinary eye care solutions. Overall, tariffs have prompted diversification of sourcing and localized production strategies.
The veterinary eye care market research report is one of a series of new reports that provides veterinary eye care market statistics, including veterinary eye care industry global market size, regional shares, competitors with a veterinary eye care market share, detailed veterinary eye care market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary eye care industry. This veterinary eye care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Veterinary eye care encompasses the specialized domain within veterinary medicine dedicated to diagnosing, treating, and managing eye-related ailments and disorders in animals. Its primary objective is to safeguard the visual health and welfare of animals, thereby augmenting their quality of life and facilitating their ability to carry out essential tasks and behaviors.
The principal product categories within veterinary eye care include ophthalmic drugs, ophthalmic devices, and ophthalmic surgery. Ophthalmic drugs are pharmaceuticals specifically formulated to address various eye-related conditions and diseases prevalent in animals, such as glaucoma, conjunctivitis, and dry eyes. These products cater to a diverse range of animal types, spanning companion animals to livestock, and are employed for indications such as eyelid abnormalities, cataracts, glaucoma, retinal complications, uveitis, conjunctivitis, corneal issues, among others. Veterinary hospitals, veterinary clinics, and similar facilities serve as the primary end-users of these products.
The veterinary eye care market consists of revenues earned by entities by providing services such as eye examinations, diagnostic testing, medical treatment, surgical procedures, and ongoing management. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary eye care market also includes sales of eye drops, ointments, and supplements, and specialized equipment and tools used in diagnostics and treatment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Veterinary Eye Care Market Characteristics
3. Veterinary Eye Care Market Supply Chain Analysis
4. Global Veterinary Eye Care Market Trends and Strategies
5. Veterinary Eye Care Market Analysis of End Use Industries
7. Global Veterinary Eye Care Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Veterinary Eye Care Total Addressable Market (TAM) Analysis for the Market
9. Veterinary Eye Care Market Segmentation
10. Veterinary Eye Care Market Regional and Country Analysis
11. Asia-Pacific Veterinary Eye Care Market
12. China Veterinary Eye Care Market
13. India Veterinary Eye Care Market
14. Japan Veterinary Eye Care Market
15. Australia Veterinary Eye Care Market
16. Indonesia Veterinary Eye Care Market
17. South Korea Veterinary Eye Care Market
18. Taiwan Veterinary Eye Care Market
19. South East Asia Veterinary Eye Care Market
20. Western Europe Veterinary Eye Care Market
21. UK Veterinary Eye Care Market
22. Germany Veterinary Eye Care Market
23. France Veterinary Eye Care Market
24. Italy Veterinary Eye Care Market
25. Spain Veterinary Eye Care Market
26. Eastern Europe Veterinary Eye Care Market
27. Russia Veterinary Eye Care Market
28. North America Veterinary Eye Care Market
29. USA Veterinary Eye Care Market
30. Canada Veterinary Eye Care Market
31. South America Veterinary Eye Care Market
32. Brazil Veterinary Eye Care Market
33. Middle East Veterinary Eye Care Market
34. Africa Veterinary Eye Care Market
36. Veterinary Eye Care Market Competitive Landscape and Company Profiles
37. Veterinary Eye Care Market Other Major and Innovative Companies
40. Veterinary Eye Care Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Veterinary Eye Care Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses veterinary eye care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for veterinary eye care? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary eye care market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Ophthalmic Drugs; Ophthalmic Devices; Ophthalmic Surgery2) By Animal Type: Companion Animal; Livestock Animals
3) By Indication: Eyelid Abnormalities; Cataract; Glaucoma; Retinal Complications; Uveitis; Conjunctivitis; Corneal Complications; Other indications
4) By End User: Veterinary Hospital; Veterinary Clinics; Other End Users
Subsegments:
1) By Ophthalmic Drugs: Anti-Inflammatory Drugs; Antibacterial Drugs; Antifungal Drugs; Lubricating Agents2) By Ophthalmic Devices: Intraocular Lenses; Tonometers; Ophthalmoscopes; Retina Imaging Systems
3) By Ophthalmic Surgery: Cataract Surgery; Glaucoma Surgery; Retinal Surgery; Corneal Transplantation
Companies Mentioned: Boehringer Ingelheim; Zoetis Inc.; Merck Animal Health; Bausch & Lomb Incorporated; Virbac; Menicon Co. Ltd.; Nutramax Laboratories Inc.; Manna Pro Products LLC; Farnam Companies; Bayer Animal Health; Beaphar; Revival Animal Health; MiracleCorp Products; Zymox; Domes Pharma; Epicur Pharma; TVM UK Animal Health Ltd.; I-MED Animal Health; an-vision GmbH; Optixcare; MENFORSAN; Nutri-Vet; Boss Pet Products Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Veterinary Eye Care market report include:- Boehringer Ingelheim
- Zoetis Inc.
- Merck Animal Health
- Bausch & Lomb Incorporated
- Virbac
- Menicon Co. Ltd.
- Nutramax Laboratories Inc.
- Manna Pro Products LLC
- Farnam Companies
- Bayer Animal Health
- Beaphar
- Revival Animal Health
- MiracleCorp Products
- Zymox
- Domes Pharma
- Epicur Pharma
- TVM UK Animal Health Ltd.
- I-MED Animal Health
- an-vision GmbH
- Optixcare
- MENFORSAN
- Nutri-Vet
- Boss Pet Products Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 75.43 Billion |
| Forecasted Market Value ( USD | $ 88.79 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
